Revealing and targeting metabolic drivers contributing to treatment escape in diffuse midline glioma

被引:0
|
作者
Frederico, Stephen C.
Neyazi, Sina
Gowda, Pruthvi
Cuong Nguyen
Trissal, Maria
Portero, Erika P.
Haley-Read, John-Paul
Anderson, Emily P.
Thomas, Craig J.
Danial, Nika N.
Filbin, Mariella G.
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Natl Ctr Adv Translat Sci, Div Preclin Innovat Chem Technol, NIH, Bethesda, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10038
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab
    Wang, Yong
    Xu, Jun
    Luo, Ningning
    Qi, Chuang
    Tao, Rongjie
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (05) : 1432 - 1435
  • [42] PRECLINICAL EFFICACY OF COMBINED RADIOTHERAPY WITH VENETOCLAX TREATMENT IN TARGETING DIFFUSE MIDLINE GLIOMAS
    Madhavan, Krishna
    Balakrishnan, Ilango
    Lakshmanachetty, Senthilnath
    Pierce, Angela
    Sanford, Bridget
    Fosmire, Susan
    Elajaili, Hanan
    Walker, Faye
    Wang, Dong
    Nozik-Grayck, Eva
    Mitra, Siddhartha
    Dahl, Nathan
    Vibhakar, Rajeev
    Venkataraman, Sujatha
    NEURO-ONCOLOGY, 2022, 24 : 32 - 33
  • [43] Targeting H3K27 Mutant Diffuse Midline Glioma Via Glucosylceramide Synthase Inhibitors
    Paret, C.
    Sandhoff, R.
    ElMalki, K.
    Wingerter, A.
    Zahnreich, S.
    Frauenknecht, K.
    Lehmann, N.
    Alexandra, R.
    Moisch, M.
    Faber, J.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S115 - S115
  • [44] The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies
    Persson, Mika L.
    Douglas, Alicia M.
    Alvaro, Frank
    Faridi, Pouya
    Larsen, Martin R.
    Alonso, Marta M.
    Vitanza, Nicholas A.
    Dun, Matthew D.
    NEURO-ONCOLOGY, 2022, 24 (09) : 1408 - 1422
  • [45] Anlotinib combined with temozolomide for the treatment of patients with diffuse midline glioma: a case report and literature review
    Feng, Yiping
    Xu, Qingsheng
    Fang, Minwei
    Hu, Chi
    TRANSLATIONAL CANCER RESEARCH, 2022, : 3876 - 3882
  • [46] SYNNOTCH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS AS A POTENTIAL TREATMENT FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)/DIFFUSE MIDLINE GLIOMA (DMG)
    Ferrerosa, Lauren
    Simic, Milos
    Watchmaker, Payal
    Diebold, David
    Pineo-Cavanaugh, Psalm
    Deucker, Jason
    Lim, Wendall
    Okada, Hideho
    NEURO-ONCOLOGY, 2022, 24 : 84 - 84
  • [47] PRECLINICAL ASSESSMENT OF A MULTIMODAL TREATMENT APPROACH WITH GIVINOSTAT, PAXALISIB, AND RADIOTHERAPY FOR DIFFUSE MIDLINE GLIOMA (DMG)
    du Chatinier, Aimee
    Meel, Michael H.
    Waranecki, Piotr
    Metselaar, Dennis S.
    Hulleman, Esther
    NEURO-ONCOLOGY, 2024, 26
  • [48] Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
    Izac J. Findlay
    Geoffry N. De Iuliis
    Ryan J. Duchatel
    Evangeline R. Jackson
    Nicholas A. Vitanza
    Jason E. Cain
    Sebastian M. Waszak
    Matthew D. Dun
    Oncogene, 2022, 41 : 461 - 475
  • [49] Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
    Findlay, Izac J.
    De Iuliis, Geoffry N.
    Duchatel, Ryan J.
    Jackson, Evangeline R.
    Vitanza, Nicholas A.
    Cain, Jason E.
    Waszak, Sebastian M.
    Dun, Matthew D.
    ONCOGENE, 2022, 41 (04) : 461 - 475
  • [50] A SYSTEMS BIOLOGY APPROACH TO DEFINING AND TARGETING CELL STATE-SPECIFIC MASTER REGULATOR DEPENDENCIES IN DIFFUSE MIDLINE GLIOMA
    Fernandez, Ester Calvo
    Wang, Junqiang
    Zhang, Xu
    Wei, Hong-Jian
    Minns, Hanna
    Griffin, Aaron
    Obradovic, Aleksandar
    Vlahos, Lukas
    Martins, Timothy
    Becker, Pamela
    Crawford, John
    Gartrell, Robyn
    Szalontay, Luca
    Zacharoulis, Stergios
    Zhang, Zhiguo
    Wechsler-Reya, Robert
    Wu, Cheng-Chia
    Califano, Andrea
    Pavisic, Jovana
    NEURO-ONCOLOGY, 2023, 25